How long before this patient crosses a clinical threshold?
PARIS AI Sepsis AEP answers that question at the bedside, for one patient, in advance, with the confidence that attaches to the estimate. Every sepsis instrument in use reads the present; this one reads forward.
Sepsis is behind one death in three worldwide, and its burden does not end at discharge.
166 million cases and 21.4 million deaths a year, by the Global Burden of Disease 2021 study. Survival is decided in hours; for survivors, readmission and late mortality follow for years.
- 21.4M
deaths a year, close to one in three worldwide
GBD 2021 - 2 to 6 h
from sepsis criteria being met to management beginning
Large cohort studies - >40%
mortality once serum lactate exceeds 4 mmol/L
Septic shock literature - $52.1bn
US hospital costs in 2021, the costliest condition
AHRQ
The burden continues after discharge
More survivors are dead at five years than were readmitted in the first year.
Sepsis-3, the septic shock criteria, NEWS2 and learned classifiers all read the present state. None warns before a defining threshold is crossed.
What the instruments in use answer
How severe is this patient now?
What the field has asked for
Will this patient cross the line, and is there time to act?
Named as a priority by the Surviving Sepsis Campaign 2026 guidelines, the NICE suspected-sepsis suite, the ADQI 28 consensus and the Global Sepsis Alliance.
One prediction, read in both directions
Where a patient is heading for a clinical boundary, the system warns ahead of it. Where a patient is not, it says so. One system, two clinical purposes, both validated by the same evidence.
Act earlier
A warning ahead of the threshold, while there is still time to prepare treatment.
Fewer alarms, confident step-down
Stability confirmed for the many patients who are safe, so observation and support can be reduced with evidence.
Auditable
Every output traceable to what was known at the moment it was made.
Six stages, one direction of travel
Join the validation programme
NHS trusts, intensive care units and research institutions are welcome to join.